2022 annual financial data

bioAffinity Technologies 2022 Net margin

Direct answer

Net margin was -169,771.25%.

Operating income was -4,011,058 USD and net income was -8,154,113 USD.
Operating cash flow was -4,070,845 USD.

Get free bioAffinity Technologies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,803 USD
Operating income
-4,011,058 USD
Net income
-8,154,113 USD
Operating cash flow
-4,070,845 USD